The U.S. Department of Justice filed an accusation against Yale University's medical school on Wednesday, alleging that the institution has continued to consider race in its admissions process in violation of federal anti-discrimination law. The action represents one of the more prominent enforcement moves by the DOJ targeting a prestigious academic medical program since the Supreme Court's landmark ruling against race-conscious admissions in 2023.

Federal officials contend that Yale's medical school admissions procedures have not been brought into full compliance with the high court's decision in Students for Fair Admissions v. Harvard and UNC, which barred the explicit use of race as a factor at institutions receiving federal funding. The DOJ's accusation signals an intent to hold elite professional schools to the same standard applied to undergraduate programs.

Yale Medical School is among the most selective and well-funded medical programs in the country, making the case a high-profile test of how the administration intends to enforce post-SFFA compliance across graduate and professional education. The school receives substantial federal funding through research grants and student financial aid, giving federal authorities significant leverage in the dispute.

The university has previously defended its commitment to diversity in its student body and has indicated it reviews its admissions policies in light of evolving legal standards. It was not immediately clear whether Yale would contest the DOJ's findings or enter into negotiations over changes to its admissions process. Similar enforcement actions against other universities have in some cases resulted in consent agreements requiring procedural reforms.